NCT05010564
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States
Clinical trial condition
Leukemia, B-Cell
Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.
121 public trials
28 recruiting studies
Leukemia, B-Cell trial results
NCT06812715
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
- Alfred Hospital Melbourne, Victoria, Australia
- Monash Medical Centre Melbourne, Victoria, Australia
NCT06834529
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- the Fifth Medical Center of Chinese People's Liberation Army General Hospital Beijing, Beijing Municipality, China
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia (CLL), +20 more
- Locations
-
- Medizinische Universität Innsbruck Innsbruck, Tyrolia, Austria
- Medizinische Universität Graz Graz, Austria
- BKH Kufstein Kufstein, Austria
- Onkologischer Schwerpunkt am Oskar-Helene-Heim Berlin, Germany
NCT06355739
- Conditions
- B Lymphoblastic Lymphoma, B Lymphocytic Leukemia, Hematologic Diseases, +12 more
- Locations
-
- Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
- InstituteHBDH Tianjin, Tianjin Municipality, China
NCT05082519
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Body Weight, Burkitt Lymphoma, +29 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital Orange County Orange, California, United States
- UCSF School of Medicine San Francisco, California, United States
- Colorado Children's Hospital Denver, Colorado, United States
NCT03899337
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- Royal Bournemouth Hospital Bournemouth, United Kingdom
- University Hospital of Wales Cardiff, United Kingdom
- Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
NCT03852407
- Conditions
- Acute Lymphoid Leukemia in Remission, Acute Myeloid Leukemia in Remission, Blood Protein Disorders, +33 more
- Locations
-
- ZNA Stuivenberg Antwerp, Belgium
- AZ Sint Jan Brugge Bruges, Belgium
- IJ Bordet Brussels, Belgium
- UZ Brussel Brussels, Belgium
Enrolling by Invitation
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
NCT02473757
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +21 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Enrolling by Invitation
Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.
NCT06762431
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukaemia (CLL), Disease Attributes, +15 more
- Locations
-
- Hematology/Oncology department Vitebsk, Select A State, Belarus